A human genetic study discovered nine highly deleterious single-nucleotide variants (SNVs) in the ARMC5 exons of myelomeningocele (MM) patients; four of the nine SNVs were proven essential for the POLR2A-specific E3 activity. The gene discussed is POLR2A; the disease is Miyoshi myopathy.